Day 1 – Saturday, October 18

Welcome!

Ophthalmology Times welcomes ophthalmic professionals from around the world to Chicago. Our four-day coverage of this year's meeting of the American Academy of Ophthalmology begins today and includes clinical updates and the latest research findings. Enjoy the meeting!

RETINA SUBSPECIALTY DAY

Although the prognosis for posterior uveal melanoma remains poor, a look at recent developments and ongoing research provides hope for better outcomes in the future, said Jerry A. Shields, MD. » Read the analysis

There are already several good reasons for ophthalmic surgeons to perform "heads-up" surgery. Further benefits to support its use are anticipated as the technology continues to evolve, said Claus Eckardt, MD. » Read the article

REFRACTIVE SUBSPECIALTY DAY

Preliminary results from the PROWL-1 and PROWL-2 studies show that at 3 months after surgery, more than 95% of patients are seeing 20/20 or better uncorrected binocularly and more than 90% have monocular uncorrected visual acuity of 20/20 or better, said Malvina B. Eydelman, MD. » Read more results

Results from 1 year of follow-up show that CXL with iontophoresis appears to be safe and effective in arresting the progression of keratoconus, said Paolo Vinciguerra, MD.
» Read the findings

FROM THE SHOW FLOOR

Abbott and Carl Zeiss Meditec announced that they have entered into a non-exclusive commercial collaboration in the United States. » Read the news

A novel medical device from BlephEx allows physicians to perform a painless, in-office procedure to treat blepharitis—thus relieving patients from the chronic and irritating symptoms of inflammatory lid disease and dry eye.
» Read about the device